Cargando…

Loss of GAS5 tumour suppressor lncRNA: an independent molecular cancer biomarker for short-term relapse and progression in bladder cancer patients

BACKGROUND: Bladder cancer (BlCa) heterogeneity and the lack of personalised prognosis lead to patients’ highly variable treatment outcomes. Here, we have analysed the utility of the GAS5 tumour-suppressor lncRNA in improving BlCa prognosis. METHODS: GAS5 was quantified in a screening cohort of 176...

Descripción completa

Detalles Bibliográficos
Autores principales:	Avgeris, Margaritis, Tsilimantou, Anastasia, Levis, Panagiotis K., Tokas, Theodoros, Sideris, Diamantis C., Stravodimos, Konstantinos, Ardavanis, Alexandros, Scorilas, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288135/ https://www.ncbi.nlm.nih.gov/pubmed/30374124 http://dx.doi.org/10.1038/s41416-018-0320-6

Ejemplares similares

tRNA-Derived Fragments (tRFs) in Bladder Cancer: Increased 5′-tRF-LysCTT Results in Disease Early Progression and Patients’ Poor Treatment Outcome
por: Papadimitriou, Maria-Alexandra, et al.
Publicado: (2020)

Epigenetic regulation of MIR145 core promoter controls miR-143/145 cluster in bladder cancer progression and treatment outcome
por: Pilala, Katerina-Marina, et al.
Publicado: (2022)

The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients
por: Avgeris, M, et al.
Publicado: (2013)

Overexpression of the GR Riborepressor LncRNA GAS5 Results in Poor Treatment Response and Early Relapse in Childhood B-ALL
por: Xagorari, Marieta, et al.
Publicado: (2021)

Evaluation of the Small Heat Shock Protein Family Members HSPB2 and HSPB3 in Bladder Cancer Prognosis and Progression
por: Gianniou, Despoina D., et al.
Publicado: (2023)

Deregulated Expression of IL-37 in Patients with Bladder Urothelial Cancer: The Diagnostic Potential of the IL-37e Isoform
por: Papasavva, Maria, et al.
Publicado: (2023)

miRNA-Based Technologies in Cancer Therapy
por: Pagoni, Maria, et al.
Publicado: (2023)

Down-regulation of kallikrein-related peptidase 5 (KLK5) expression in breast cancer patients: a biomarker for the differential diagnosis of breast lesions
por: Avgeris, Margaritis, et al.
Publicado: (2011)

The lysine‐specific methyltransferase KMT2C/MLL3 regulates DNA repair components in cancer
por: Rampias, Theodoros, et al.
Publicado: (2019)

miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myeloma
por: Papadimitriou, Maria-Alexandra, et al.
Publicado: (2023)

Targeted nanopore sequencing for the identification of novel PRMT1 circRNAs unveils a diverse transcriptional profile of this gene in breast cancer cells
por: Papatsirou, Maria, et al.
Publicado: (2023)

Recent Advances in Genome-Engineering Strategies
por: Boti, Michaela A., et al.
Publicado: (2023)

BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer
por: Liao, Tian, et al.
Publicado: (2016)

A New Story of the Three Magi: Scaffolding Proteins and lncRNA Suppressors of Cancer
por: Kotelevets, Larissa, et al.
Publicado: (2021)

Special Issue “Prostate Cancer: Recent Advances in Diagnostics and Treatment Planning”
por: Tokas, Theodoros
Publicado: (2022)

Discovery and Comprehensive Characterization of Novel Circular RNAs of the Apoptosis-Related BOK Gene in Human Ovarian and Prostate Cancer Cells, Using Nanopore Sequencing
por: Kontos, Christos K., et al.
Publicado: (2023)

tRNA(GlyGCC)-Derived Internal Fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and Progression
por: Panoutsopoulou, Konstantina, et al.
Publicado: (2021)

LncRNA PELATON, a Ferroptosis Suppressor and Prognositic Signature for GBM
por: Fu, Haijuan, et al.
Publicado: (2022)

Novel Nested-Seq Approach for SARS-CoV-2 Real-Time Epidemiology and In-Depth Mutational Profiling in Wastewater
por: Avgeris, Margaritis, et al.
Publicado: (2021)

The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic Leukemias
por: Tzifi, Flora, et al.
Publicado: (2012)

Novel Tumor Suppressor lncRNA Growth Arrest-Specific 5 (GAS5) In Human Cancer
por: Yu, Yaya, et al.
Publicado: (2019)

miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment
por: Piatopoulou, Despina, et al.
Publicado: (2017)

Interplay between Sulfur Assimilation and Biodesulfurization Activity in Rhodococcus qingshengii IGTS8: Insights into a Regulatory Role of the Reverse Transsulfuration Pathway
por: Martzoukou, Olga, et al.
Publicado: (2022)

LncRNA loc285194 is a p53-regulated tumor suppressor
por: Liu, Qian, et al.
Publicado: (2013)

Molecular and Cellular Mechanisms of Action of Tumour Suppressor GAS5 LncRNA
por: Pickard, Mark R., et al.
Publicado: (2015)

A review of current evidence about lncRNA MEG3: A tumor suppressor in multiple cancers
por: Xu, Jie, et al.
Publicado: (2022)

Robotic-assisted microsurgery in andrology: a systematic review
por: Douroumis, Konstantinos, et al.
Publicado: (2023)

Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer
por: Li, Yongsheng, et al.
Publicado: (2015)

Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negativeatients
por: Scorilas, A, et al.
Publicado: (2001)

Reciprocal control of lncRNA-BCAT1 and β-catenin pathway reveals lncRNA-BCAT1 long non-coding RNA acts as a tumor suppressor in colorectal cancer
por: Xie, Fei, et al.
Publicado: (2017)

Truncated Isoforms of lncRNA ANRIL Are Overexpressed in Bladder Cancer, But Do Not Contribute to Repression of INK4 Tumor Suppressors
por: Hoffmann, Michèle J., et al.
Publicado: (2015)

MicroRNA-675-5p Overexpression Is an Independent Prognostic Molecular Biomarker of Short-Term Relapse and Poor Overall Survival in Colorectal Cancer
por: Christodoulou, Spyridon, et al.
Publicado: (2023)

Identification of lncRNA and mRNA Expression Profile in Relapsed Graves’ Disease
por: Yao, Qiuming, et al.
Publicado: (2021)

HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study
por: Economopoulou, Panagiota, et al.
Publicado: (2019)

Predictors for the development of cholangiocarcinoma and hepatocellular carcinoma: in search for the most accurate biomarker
por: Tzovaras, Alexandros A., et al.
Publicado: (2011)

Surveying lncRNA-lncRNA cooperations reveals dominant effect on tumor immunity cross cancers
por: Shao, Tingting, et al.
Publicado: (2022)

A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma
por: Papanota, Aristea-Maria, et al.
Publicado: (2021)

Functions of lncRNA HOTAIR in lung cancer
por: Loewen, Gregory, et al.
Publicado: (2014)

LncRNA & Wnt signaling in colorectal cancer
por: Javed, Zeeshan, et al.
Publicado: (2020)

Editorial: The Role of lncRNA in Cancer Metabolism
por: Huang, Guo-Liang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_51irl22tns7ophvk3o9981jg6n